Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | RP11-307N16.6 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | ATP7B | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | SOX6 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | PFKFB3 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | APOC4 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | CCL25 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | LY6L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | N4BP2L1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
mRNA | MRGPRG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |